AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 251 min read$HYPR

HALE BRETT sold $6K of HYPR

HALE BRETT (CFO and CAO) sold 7,345 shares of Hyperfine, Inc. (HYPR) at $0.85 on 2026-08-24.

Original reporting
SEC EDGAR · HALE BRETT
Published Aug 25, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HYPR
Neutral
high confidence
Mentioned
$HYPR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HYPRNeutralLow
01

Why it matters

The disclosed sale is modest and not pre‑arranged, suggesting limited informational value for price direction.

02

Market read

Minor insider sell; unlikely to affect market perception or price.

03

What to watch

Potential upcoming financing round or strategic shift not disclosed; sale may be personal liquidity need.

Relevance 3/10Novelty 4/10Timing: filing date 2026-08-25

Background

Form 4 filings disclose insider transactions; traders monitor them for signals of confidence or distress.

Company-level read

Ticker impact

$HYPRNeutralHigh confidence
Context

CFO/CAO Hale Brett sold 7,345 shares of Hyperfine at $0.8540, total $6.3K, reducing his stake.

Expected impact

No significant impact; price may stay flat or dip slightly on short‑term selling pressure.

Evidence & confidence

The transaction size is small relative to market cap and typical daily volume; insider is a C‑suite officer but sale is not pre‑arranged and represents a modest portion of holdings.

Market effects

Sector

No broader sector impact; hyper‑fine medical device sector unchanged.

Regional

U.S. market only; no regional ripple.

Global

Limited; only relevant to Hyperfine shareholders.

Counterpoint

What could challenge this read

The sale could signal insider concern about near‑term valuation, but size is too small to be meaningful.

Key entities

  • Company
    Hyperfine, Inc.

    Medical device maker listed on NASDAQ under ticker HYPR.

  • Person
    Hale Brett

    Chief Financial Officer and Chief Accounting Officer of Hyperfine.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HYPR insider trading history →

Related articles

OCT 8
$HYPRMedAI 9/10

Hyperfine expects Q3 revenue of $6M; shares jump 9%

Hyperfine HYPR reported preliminary Q3 2026 revenue of $6.0M, beating estimates and up 53% sequentially. Shares rose 9% premarket. Net cash burn improved 29% QoQ. Full-year revenue guidance remains $20M-$22M, with cash burn expected to decline 10% YoY. Results will be detailed on Nov 9, 2026.

tradingview.com3 min
OCT 8
$HYPRMed

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to…

Hyperfine, Inc. (HYPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million Preliminary Revenue Represents 53% Sequential Quarterly Growth; Company Reaffirms 2026 Financial Gu

SEC EDGAR 8-K2 min
AUG 14
$HYPRMedAI 8/10

Hyperfine (HYPR) Q2 2026 Earnings Call Transcript

Hyperfine (HYPR) reported Q2 2026 revenue of $3.9 million, up 45% year over year, and first-half revenue of $7.8 million, up 62%. Gross margin was 50.7%. Net loss was $9.3 million. Cash was $43.5 million at June 30, 2026. Full-year 2026 guidance: revenue $20-$22 million, gross margin 50%-55%, cash burn $26-$28 million.

fool.com7 min
AUG 6
$HYPRHigh

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

Hyperfine, Inc. (HYPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hyperfine, Inc. Reports Second Quarter 2026 Financial Results GUILFORD, Connecticut, August 6, 2026 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered

SEC EDGAR 8-K6 min